Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss

Follow Drugslib on

By HealthDay Staff HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 22, 2026.

via HealthDay

WEDNESDAY, April 22, 2026 — A new effort to prepare for future bird flu outbreaks is moving forward, despite a major funding setback.

The American pharmaceutical and biotechnology company Moderna has initiated a large clinical trial around a vaccine designed to protect people against bird flu, enrolling participants in the United States and Britain.

The study is expected to include about 4,000 adults. The company said the first participants have already received a shot.

The vaccine uses messenger RNA (mRNA), the same technology used in many COVID-19 vaccines.

Earlier research involving about 300 healthy adults showed promising results for safety and immune response, Moderna said.

The trial had been delayed after the U.S. Department of Health and Human Services (HHS) cut funding last year that had been set aside to support the development of pandemic flu vaccines, The Washington Post reported.

Despite the blow, Moderna secured as much as $54.3 million from the Coalition for Epidemic Preparedness Innovations, a global group that supports vaccine development.

Moderna CEO Stéphane Bancel called the trial an important step to “strengthen global pandemic preparedness," The Post reported.

“Our platform technology’s efficiency and scalability are critical to supporting global health security and responding to potential future threats,” he said.

The cuts came after Trump administration officials began to question whether mRNA vaccines should continue to receive public funding at all.

In a statement, HHS said it reduced mRNA vaccine funding after a "rigorous review," adding the technology "remains under-tested" for some uses, THe Post said.

"Last year, HHS wound down its investments in mRNA vaccines for upper respiratory viruses because they do not protect effectively against infections from mutating strain of viruses such as COVID and flu," HHS spokesman Andrew Nixon said in a statement.

"Also, these companies had already been massively subsidized by the government, and we decided to reinvest the money in other more promising technologies," he added.

At the same time, officials said they see the potential for mRNA technology in other areas, such as cancer.

Experts noted that mRNA vaccines used during the pandemic were shown to be safe and effective, and they are able to be developed more quickly than traditional vaccines.

Sources

  • The Washington Post, April 21, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-23 02:08

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords